Standardized classification schemes in reporting oncologic PET/CT.

Area of Science:

• Oncology
• Medical Imaging
• Nuclear Medicine

Background:

• Clear and concise imaging reports are crucial for physician communication and patient care.
• Standardized reporting guidelines enhance the utility of imaging for clinical decision-making.
• Several classification schemes for Positron Emission Tomography (PET) have emerged recently.

Purpose of the Study:

• To review and summarize frequently used PET imaging classification schemes in oncology.
• To provide guidance on interpreting and reporting specific PET scans used in various cancers.
• To highlight the importance of standardized reporting for effective clinical application.

Main Methods:

• Literature review of existing classification schemes and reporting guidelines for PET in oncology.
• Focus on 18F-FDG PET for lymphoma, multiple myeloma, melanoma, and head and neck cancers.
• Inclusion of PSMA-ligand PET for prostate cancer and 68Ga-DOTA-peptide PET for neuroendocrine tumors (NET).

Main Results:

• Identification of prevalent classification systems for 18F-FDG PET in common oncologic indications.
• Overview of PSMA-ligand PET reporting standards for prostate cancer.
• Summary of 68Ga-DOTA-peptide PET interpretation guidelines for NET.
• Emphasis on the need for evidence-based conclusions in PET reports.

Conclusions:

• Standardized classification schemes are vital for consistent interpretation and reporting of oncologic PET imaging.
• This review consolidates key reporting guidelines across several important cancer types.
• Adoption of these guidelines can improve communication and support clinical decision-making in patient management.